Combining serum peptide signatures with International Federation of Gynecology and Obstetrics (FIGO) risk score to predict the outcomes of patients with gestational trophoblastic neoplasia (GTN) after first-line chemotherapy

BACKGROUND: Gestational trophoblastic neoplasia (GTN) is a group of clinically rare tumors that develop in the uterus from placental tissue. Currently, its satisfactory curability derives from the timely and accurately classification and refined management for patients. This study aimed to discover...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fei, Wang, Zi-ran, Ding, Xue-song, Yang, Hua, Guo, Ye, Su, Hao, Wan, Xi-run, Wang, Li-juan, Jiang, Xiang-yang, Xu, Yan-hua, Chen, Feng, Cui, Wei, Feng, Feng-zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634134/
https://www.ncbi.nlm.nih.gov/pubmed/36338720
http://dx.doi.org/10.3389/fonc.2022.982806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634134/
https://www.ncbi.nlm.nih.gov/pubmed/36338720
http://dx.doi.org/10.3389/fonc.2022.982806

Ejemplares similares